Back
Celldex Therapeutics Vs. Aritzia Industry Stock Comparison
Sell
26
CLDX
Celldex Therapeutics
Last Price:
26.88
Seasonality Move:
17.85%
Sell
40
ATZAF
Aritzia
Last Price:
33.13
Seasonality Move:
14.48%
Sell
26
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $27.03. The Score for CLDX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- CLDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Aritzia (ATZAF)
is a Sell
Is Aritzia a Buy, Sell or Hold?
- The current Aritzia [ATZAF] share price is $32.80. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $27.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight selling pressure.
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.67 | Sell |
| Relative Strength Index (14 RSI): | 41.98 | Sell |
| Chaikin Money Flow: | -103281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.19 - 29.63) | Sell |
| Bollinger Bands (100): | (29.76 - 40.42) | Sell |
ATZAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.9 | Sell |
| Relative Strength Index (14 RSI): | 50.73 | Buy |
| Chaikin Money Flow: | 7616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.43 - 34.95) | Buy |
| Bollinger Bands (100): | (30.1 - 35.52) | Sell |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.26 | Buy |
| 20-day SMA: | 27.29 | Sell |
| 50-day SMA: | 33.26 | Sell |
| 200-day SMA: | 37.3 | Sell |
| 8-day EMA: | 26.58 | Buy |
| 20-day EMA: | 27.72 | Sell |
| 50-day EMA: | 31.04 | Sell |
| 200-day EMA: | 35.1 | Sell |
ATZAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.79 | Buy |
| 20-day SMA: | 31.82 | Buy |
| 50-day SMA: | 34.06 | Sell |
| 200-day SMA: | 29.5 | Buy |
| 8-day EMA: | 31.34 | Buy |
| 20-day EMA: | 32.22 | Buy |
| 50-day EMA: | 33.01 | Sell |
| 200-day EMA: | 29.97 | Buy |
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.84 per share.
Aritzia Earnings Growth & ATZAF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.
Celldex Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aritzia Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||